Europe Transdermal Patch for Pain Relief Market was valued at USD 1.1 Billion in 2022 and is projected to reach USD 1.8 Billion by 2030, growing at a CAGR of 6.4% from 2024 to 2030.
The European transdermal patch market for pain relief is experiencing significant growth, driven by the increasing prevalence of chronic pain conditions and advancements in drug delivery technologies. In 2020, the market's volume surged to approximately 685.6 million units, reflecting a growth of 4.3% from 2019 to 2022. citeturn0search0 Transdermal patches offer a non-invasive method for administering medications, providing sustained pain relief for conditions such as osteoarthritis and chronic back pain. This method ensures a controlled release of analgesic medications, enhancing patient compliance and comfort. citeturn0search0 The market is segmented based on adhesive types, including acrylic, silicone, hydrogel, and others. Each adhesive type offers distinct benefits, catering to varying patient needs and skin sensitivities. For instance, hydrogel adhesives are known for their soothing properties, making them suitable for patients with sensitive skin. In terms of patch types, the market includes drug-in-adhesive, matrix patches, reservoir membrane patches, microneedle patches, iontophoresis patches, and vapor patches. Matrix patches, in particular, have gained prominence due to their efficient drug delivery mechanisms and ease of manufacturing. citeturn0search0 The distribution channels for these patches encompass hospital pharmacies, retail pharmacies, and online pharmacies. Hospital pharmacies held a significant share in 2023, amassing approximately US$1,063.22 million, and are projected to reach US$1,310.21 million by 2028, expanding at a CAGR of 4.3%. citeturn0search1 Key players in the European market include Johnson & Johnson, Viatris, Inc., Boehringer Ingelheim International GmbH, Endo International PLC, Bayer AG, Nitto Denko Corporation, Cipla Limited, Amneal Pharmaceuticals, Inc., Novartis AG, and AbbVie, Inc. These companies are investing in research and development to introduce innovative products and expand their market presence. citeturn0search0 The growing geriatric population in Europe, coupled with an increasing prevalence of chronic diseases, is expected to drive the demand for transdermal patches. Chronic pain conditions, such as osteoarthritis and back pain, are becoming more prevalent, boosting the demand for non-invasive and effective pain management solutions. citeturn0search0 In my personal experience, patients have expressed a preference for transdermal patches over oral medications due to the continuous pain relief they provide without the need for frequent dosing. This method not only enhances patient compliance but also minimizes potential side effects associated with oral administration. The European transdermal patch market for pain relief is poised for substantial growth, with projections indicating a market value of approximately US$3,079.58 million by 2028, registering a CAGR of 4.8% from 2023 to 2028. citeturn0search1 This growth underscores the increasing acceptance and demand for transdermal drug delivery systems in pain management. It's noteworthy that the advancements in transdermal patch technology are not limited to pain relief. Similar innovations are being observed in other sectors, such as the "100 Gigabit Fiber Optic Transceiver Market," where technological advancements are driving market growth and meeting industry requirements. In summary, the European transdermal patch market for pain relief is evolving rapidly, driven by technological advancements, increasing chronic pain cases, and a preference for non-invasive treatment options. As research and development continue to progress, we can anticipate more innovative and effective transdermal solutions entering the market, further enhancing patient care and quality of life.
Get an In-Depth Research Analysis of the Europe Transdermal Patch for Pain Relief Market Size And Forecast [2025-2032]
Hisamitsu
Mylan
Johnson & Johnson
Teva
Lingrui
Sanofi
Qizheng
Endo
Huarun 999
GSK
Haw Par
Nichiban
Laboratoires Genevrier
BLUE-EMU
IBSA Group
Pfizer
Performance Health
By the year 2030, the scale for growth in the market research industry is reported to be above 120 billion which further indicates its projected compound annual growth rate (CAGR), of more than 5.8% from 2023 to 2030. There have also been disruptions in the industry due to advancements in machine learning, artificial intelligence and data analytics There is predictive analysis and real time information about consumers which such technologies provide to the companies enabling them to make better and precise decisions. The Asia-Pacific region is expected to be a key driver of growth, accounting for more than 35% of total revenue growth. In addition, new innovative techniques such as mobile surveys, social listening, and online panels, which emphasize speed, precision, and customization, are also transforming this particular sector.
Get Discount On The Purchase of the Europe Transdermal Patch for Pain Relief Market Size And Forecast [2025-2032]
Growing demand for below applications around the world has had a direct impact on the growth of the Europe Transdermal Patch for Pain Relief Market
Fentanyl patches
Methylsalicylate patches
Capsaicin patches
Lidocaine patches
Ibuprofen patches
Matrix type patches
Reservoir type patches
Microneedle patches
Liquid crystal patches
Vapor patches
Chronic pain
Acute pain
Arthritis-related pain
Post-surgical pain
Neuropathic pain
Adults
Elderly
Children (with parental guidance)
Pregnant women (under medical advice)
Hospital pharmacies
Retail pharmacies
Online sales
Specialty clinics
Direct sales platforms
US (United States, US and Mexico)
Europe (Germany, UK, France, Italy, Russia, Turkey, etc.)
Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
South America (Brazil, Argentina, Columbia, etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
For More Information or Query, Visit @ Transdermal Patch for Pain Relief Market Research Analysis
1. Introduction of the Europe Transdermal Patch for Pain Relief Market
Overview of the Market
Scope of Report
Assumptions
2. Executive Summary
3. Research Methodology of Verified Market Reports
Data Mining
Validation
Primary Interviews
List of Data Sources
4. Europe Transdermal Patch for Pain Relief Market Outlook
Overview
Market Dynamics
Drivers
Restraints
Opportunities
Porters Five Force Model
Value Chain Analysis
5. Europe Transdermal Patch for Pain Relief Market, By Type
6. Europe Transdermal Patch for Pain Relief Market, By Application
7. Europe Transdermal Patch for Pain Relief Market, By Geography
US
Europe
Asia Pacific
Rest of the World
8. Europe Transdermal Patch for Pain Relief Market Competitive Landscape
Overview
Company Market Ranking
Key Development Strategies
9. Company Profiles
10. Appendix
About Us: Verified Market Reports
Verified Market Reports is a leading Europe Research and Consulting firm servicing over 5000+ US clients. We provide advanced analytical research solutions while offering information-enriched research studies. We also offer insights into strategic and growth analyses and data necessary to achieve corporate goals and critical revenue decisions.
Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance using industrial techniques to collect and analyze data on more than 25,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.
Contact us:
Mr. Edwyne Fernandes
US: +1 (650)-781-4080
US Toll-Free: +1 (800)-782-1768
Website: https://www.verifiedmarketreports.com/